Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2003
11/04/2003US6642248 Antitumor, anticancer agent
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642237 Inhibitors of HIV protease and inhibitors of HIV replication, used in the prevention or treatment of infection by HIV and treatment for AIDS
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642180 Biphenyl-substituted cyclic ketoenols as pesticides
11/04/2003US6641889 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer
10/2003
10/31/2003WO2002085909A1 9-deazaguanine derivatives as inhibitors of gsk-3
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089437A1 A trifluoroacetic acid process to prepare [2,3-b]pyridine intermediates
10/30/2003WO2003089423A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents
10/30/2003WO2003089416A1 Substituted pyrimidine-2,4(1h,3h)-diones for use as matrix metalloproteinase (mmp) inhibitors
10/30/2003WO2003089413A1 Pharmacia corporation
10/30/2003WO2003088963A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003004501A3 (hetero) aryl substituted benzofurans as 5-ht ligands
10/30/2003US20030204088 Reacting a 2,3-dihydro-p-dioxino(2,3-g)quinoline-6-(4-N-methyl piperazine compound with a pyrano(3,4-c)pyridine-3,8-dione compound to form the intermediate
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203817 Photochromic acrylic copolymers crosslinked with leuco dyes
10/30/2003CA2488929A1 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine a2a receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation related diseases
10/30/2003CA2482712A1 Compounds useful in preparing camptothecin derivatives
10/29/2003EP1357114A1 Substituted pyrimidin-2,4(1H,3H)-diones as inhibitors of Matrix Metalloproteinases (MMP)
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/29/2003EP1007527B1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
10/29/2003EP0923566B1 High molecular weight polymer-based prodrugs
10/29/2003CN1452623A 4-phenyl substd. tetrahydroisoquinolines and therapeutic use thereof
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/29/2003CN1125824C Antiparasitic marcfortines
10/29/2003CN1125815C Method for synthesis of quinoline derivatives
10/28/2003US6638960 Use as microbicides, especially fungicides, in crop protection
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638925 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
10/28/2003US6638499 A nitrogen group containing linkage which is attached one end with a polyoxyalkylene glycol polymer and other end is coupled with a drug; useful for drug delivery
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/23/2003WO2003087104A1 Heterocyclic compounds
10/23/2003WO2003087103A1 Thienyl compounds
10/23/2003WO2003087102A1 Furyl compounds
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003087071A1 Sulfonamide derivatives
10/23/2003WO2003086398A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003WO2003086397A1 Medicine for treating cancer
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2002080150A3 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003CA2482313A1 Heterocyclic compounds
10/23/2003CA2482312A1 Thienyl compounds
10/23/2003CA2481240A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
10/23/2003CA2448525A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353673A1 Camptothecin derivatives
10/22/2003EP1087967B1 1,3-oxazoline and 1,3-thiazoline derivatives, method for producing the same and their use as pesticides
10/22/2003EP1003749B1 8-SUBSTITUTED-9H-1,3-DIOXOLO/4,5-h/2,3/BENZODIAZEPINE DERIVATES, AS AMPA/KAINATERECEPTOR INHIBITORS
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451009A Glucocortiocoid-selective antinflammatory agents
10/22/2003CN1451008A Pyranoindoles for treating alaucoma
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450067A High-efficient production method for 10-hydroxycamptothecine
10/22/2003CN1125071C Phthalocyanine and use of phthalocyanine as marking agent
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635770 Process for producing hexahydrothieno (3,4-D)immidazole-2,4-diones
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
10/16/2003WO2003045952A3 Condensed camptothecins as antitumor agents
10/16/2003WO2003041660A3 Solubilized topoisomerase poisons
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
10/16/2003US20030195244 Nitrogen compounds such as (6-Methoxy-1H-indol-3-yl)-(3,4,5-trimethoxy-phenyl)-methanone, administered for prophylaxis of cancer; angiogenesis inhibitors
10/16/2003US20030195236 Heterocyclic imines such as 2-methyl-3-toluoyloxy-4-formyl-5-hydroxymethylpyridine, used for prophylaxis of vitamin B6 deficiency, cardiovascular disorders or melanomas
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195188 Pyridine and quinoline derivatives
10/16/2003US20030194698 E2 displacement assay for identifying inhibitors of HPV
10/16/2003US20030194579 Yellow light emitting compound and organic electroluminescent device of the same
10/16/2003US20030194375 Anti-epileptogenic agents
10/16/2003CA2481888A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351695A1 Camptothecin compounds with a sulfhydryl group
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003EP0986564B1 6-SUBSTITUTED 1,2,4A,5A,8A,8A HEXAHYDRO- AND 1,2,3,4,4A,5A,8A,8B-OCTAHYDRO-6H-PYRROLO[3',4':4,5]FURO[3,2-b]PYRID-8(7H)-ONE DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003CN1449443A 真菌细胞壁合成基因 Fungal cell wall synthesis genes
10/14/2003US6632809 Gyrase inhibitors and uses thereof
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 298